Table 2.

Demographic, clinical, and postmortem characteristics of nAD and AD groups

Cohorts	nAD	AD
	n = 20	n = 20
Gender	13F:7M	11F:9M
Age of Death (y, mean±SD)	85±1.3	80±1.3
Age of AD onset (y, mean±SD)	N/A	70±1.4
Duration of AD (y, mean±SD)	N/A	10±1.0
Braak stage	0–II: 19	0–II: 0
	III–IV: 1	III–IV: 2
	V–VI: 0	V–VI: 18
APOE genotype	ɛ4/–: 2	ɛ4/–: 3
	ɛ4/ɛ4 : 1	ɛ4/ɛ4 : 3
Postmortem delay (h, mean±SD)	43.3±5.6	42.9±6.1

N/A, non-applicable.